Re: longevity, ITP didn't find any significant impact from metformin. Afaik they're the most rigorous testers of this sort of thing, so that's pretty significant to me.
>Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive of an added benefit, based on historical comparison with earlier studies of rapamycin given alone.
ziddoap|1 year ago
Interventions Testing Program (by The National Institute on Aging) for the unfamiliar, like me.
klipklop|1 year ago
Also.
>Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive of an added benefit, based on historical comparison with earlier studies of rapamycin given alone.